These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26598380)

  • 41. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
    Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
    Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Tumor necrosis receptor associated periodic syndrome (TRAPS): State of the art].
    Georgin-Lavialle S; Kone-Paut I; Delaleu J; Sarrabay G; Grateau G; Touitou I; Hentgen V
    Rev Med Interne; 2018 Apr; 39(4):256-264. PubMed ID: 29525418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autosomal dominant familial periodic fever patient with a missense variant c.215G>A (p.Cys72Tyr) in TNFRSF1A gene presenting as neutrophilia.
    Rajpal S; Jamwal M; Lad D; Das R
    Eur J Med Genet; 2021 May; 64(5):104191. PubMed ID: 33753323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation.
    Hoffmann F; Lohse P; Stojanov S; Shin YS; Renner ED; Kéry A; Zellerer S; Belohradsky BH
    Eur J Hum Genet; 2005 Apr; 13(4):510-2. PubMed ID: 15657603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without TNFRSF1A Mutations Successfully Treated with Tocilizumab.
    Hosoya T; Mizoguchi F; Hasegawa H; Miura K; Koike R; Kubota T; Miyasaka N; Kohsaka H
    Intern Med; 2015; 54(16):2069-72. PubMed ID: 26278305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
    Delaleu J; Deshayes S; Rodrigues F; Savey L; Rivière E; Silva NM; Aouba A; Amselem S; Rabant M; Grateau G; Giurgea I; Georgin-Lavialle S
    Rheumatology (Oxford); 2021 Dec; 60(12):5775-5784. PubMed ID: 33715002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion.
    Turner MD; Chaudhry A; Nedjai B
    Biosci Rep; 2012 Apr; 32(2):105-12. PubMed ID: 22115362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome.
    Cantarini L; Lucherini OM; Cimaz R; Baldari CT; Bellisai F; Rossi Paccani S; Laghi Pasini F; Capecchi PL; Sebastiani GD; Galeazzi M
    Int J Immunopathol Pharmacol; 2009; 22(4):1051-8. PubMed ID: 20074469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
    La Torre F; Muratore M; Vitale A; Moramarco F; Quarta L; Cantarini L
    Rheumatol Int; 2015 Nov; 35(11):1943-7. PubMed ID: 26048626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First Case of TNF-Receptor-Associated Autoinflammatory Syndrome (TRAPS) in Bulgaria.
    Solakov PT
    Folia Med (Plovdiv); 2016 Sep; 58(3):211-214. PubMed ID: 27760004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Somatic mosaicism in adult-onset TNF receptor-associated periodic syndrome (TRAPS).
    Kontzias A; Zarabi SK; Calabrese C; Wang Y; Judis L; Yao Q; Cheng YW
    Mol Genet Genomic Med; 2019 Aug; 7(8):e791. PubMed ID: 31397119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Autoinflammatory diseases].
    Russo RA; Katsicas MM
    Medicina (B Aires); 2016; 76(3):166-72. PubMed ID: 27295706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel TNFRSF1 gene mutation in a Turkish family: a report of three cases.
    Cosan F; Yazici A; Yılmazer B; Gul A; Ustek D; Cefle A
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S83-5. PubMed ID: 20532935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndrome.
    Nedjai B; Hitman GA; Yousaf N; Chernajovsky Y; Stjernberg-Salmela S; Pettersson T; Ranki A; Hawkins PN; Arkwright PD; McDermott MF; Turner MD
    Arthritis Rheum; 2008 Jan; 58(1):273-83. PubMed ID: 18163488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and Genetic Features of Patients With TNFRSF1A Variants in Japan: Findings of a Nationwide Survey.
    Ueda N; Ida H; Washio M; Miyahara H; Tokunaga S; Tanaka F; Takahashi H; Kusuhara K; Ohmura K; Nakayama M; Ohara O; Nishikomori R; Minota S; Takei S; Fujii T; Ishigatsubo Y; Tsukamoto H; Tahira T; Horiuchi T
    Arthritis Rheumatol; 2016 Nov; 68(11):2760-2771. PubMed ID: 27332769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mosaic variants in TNFRSF1A: an emerging cause of tumour necrosis factor receptor-associated periodic syndrome.
    Assrawi E; Louvrier C; El Khouri E; Delaleu J; Copin B; Dastot-Le Moal F; Piterboth W; Legendre M; Karabina SA; Grateau G; Amselem S; Giurgea I
    Rheumatology (Oxford); 2022 Dec; 62(1):473-479. PubMed ID: 35640127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
    Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
    Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
    Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patients with tumour necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS) are hypersensitive to Toll-like receptor 9 stimulation.
    Negm OH; Singh S; Abduljabbar W; Hamed MR; Radford P; McDermott EM; Drewe E; Fairclough L; Todd I; Tighe PJ
    Clin Exp Immunol; 2019 Sep; 197(3):352-360. PubMed ID: 31009059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study.
    Cantarini L; Lucherini OM; Brucato A; Barone L; Cumetti D; Iacoponi F; Rigante D; Brambilla G; Penco S; Brizi MG; Patrosso MC; Valesini G; Frediani B; Galeazzi M; Cimaz R; Paolazzi G; Vitale A; Imazio M
    Clin Res Cardiol; 2012 Jul; 101(7):525-31. PubMed ID: 22311714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.